EXEMPA LIN MET XR Tablets 10/5/1000mg (14s) combine Empagliflozin, Linagliptin, and Metformin (Extended Release) to provide comprehensive control of type 2 diabetes mellitus. This triple-action formula works by enhancing insulin sensitivity, reducing glucose production, increasing insulin secretion, and promoting glucose excretion through urine. EXEMPA LIN MET XR helps maintain stable blood sugar levels, supports weight management, and lowers the risk of diabetes-related complications when used with a healthy diet and regular exercise.
Uses:
-
For the management of type 2 diabetes mellitus.
-
Helps in controlling high blood glucose levels.
-
Reduces risk of heart and kidney complications associated with diabetes.
Benefits:
-
Triple-action control for optimal glycemic management.
-
Supports weight loss and improved metabolism.
-
Extended-release formula ensures sustained blood sugar control.
-
Once-daily dosing for convenience and better adherence.
-
May help reduce HbA1c levels effectively.
Side Effects:
-
Common: Increased urination, nausea, diarrhea, or thirst.
-
Occasional: Hypoglycemia (when used with other antidiabetics), urinary tract infections, or stomach upset.
-
Rare: Dehydration, allergic reactions, or lactic acidosis (seek medical advice if symptoms occur).
#Hashtags:
#ExempaLinMetXR #Empagliflozin #Linagliptin #MetforminXR #Type2Diabetes #BloodSugarControl #DiabetesCare #Antidiabetic #GlycemicControl #HealthyLiving #SugarControl #DiabetesManagement